logo-large
  • Browse Categories

Publications by authors named "Joni Dy"

Claim this Profile
H
Heart rate decrease during crizotinib treatment and potential correlation to clinical response.
Sai-Hong Ignatius Ou, Wilson P Tong, Michele Azada, Christina Siwak-Tapp, Joni Dy

Cancer· June 2013


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic profound sinus bradycardia (heart rate ≤45) in non-small cell lung cancer patients treated with crizotinib.
Sai-Hong Ignatius Ou, Michele Azada, Joni Dy, Jonathan A Stiber

J Thorac Oncol· December 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of crizotinib (PF02341066), a dual mesenchymal-epithelial transition (MET) and anaplastic lymphoma kinase (ALK) inhibitor, in a non-small cell lung cancer patient with de novo MET amplification.
Sai-Hong Ignatius Ou, Eunice L Kwak, Christina Siwak-Tapp, Joni Dy, Kristin Bergethon

J Thorac Oncol· May 2011


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: